Alerts will be sent to your verified email
Verify Email
ALIVUS
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Glenmark Life Sciences is a leading manufacturer of specialized APIs for chronic therapeutic areas such as cardiovascular, CNS, and pain management, with a strong market presence in various specialized products.
Alivus Life Sciences major competitors are Neuland Laboratories, IOL Chem & Pharma, Granules India, Shilpa Medicare, Acutaas Chemicals, Aarti Pharmalabs, Supriya Lifescience.
Market Cap of Alivus Life Sciences is ₹12,327 Crs.
While the median market cap of its peers are ₹8,995 Crs.
Alivus Life Sciences seems to be less financially stable compared to its competitors.
Altman Z score of Alivus Life Sciences is 8.81 and is ranked 4 out of its 8 competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | May | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Jun Sep Dec | |||||||||||||
| Investor Presentation | May | Mar Jun Sep Dec | Mar Jun Sep Dec | Feb Mar Apr Jun Aug Sep Nov Dec | Mar Jun Sep Dec | |||||||||||||
| Conference Call | Mar | Mar Jun Sep Dec | Mar Jun Sep Dec | Jun Sep Dec | ||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
